2seventy bio, Inc.

NASDAQ:TSVT

4.87 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 8.96712.43510.68412.03436.04841.62156.17713.40813.4828.42916.03319.2577.32811.9019.90518.434109.891109.891
Cost of Revenue 5.1296.6066.1774.9594.5174.29515.3250.3774.6545.8630.4050.3210.1581.7041.4991.31878.95678.956
Gross Profit 3.8385.8294.5077.07531.53137.32640.85213.0318.8282.56615.62818.937-2.8310.1978.40617.11630.93630.936
Gross Profit Ratio 0.4280.4690.4220.5880.8750.8970.7270.9720.6550.3040.9750.983-0.3860.8570.8490.9290.2820.282
Reseach & Development Expenses 14.33741.82448.18751.31559.9868.24649.31261.73968.43969.24559.54461.13163.69277.57168.88272.25377.66677.666
General & Administrative Expenses 000000000000000000
Selling & Marketing Expenses 000000000000000000
SG&A 9.85712.65916.20113.00419.48920.7218.70119.6117.27823.86124.4822.99621.40224.62721.94622.10523.42423.424
Other Expenses 1.4340.646-0.5342.7042.8122.6432.561-0.624-0.6444.7627.3095.2373.9295.1744.7444.33900
Operating Expenses 24.19454.48364.38864.31979.46988.96668.01381.34985.71793.10684.02484.12785.094102.19890.82894.35816.55616.556
Operating Income -20.356-48.654-59.881-77.968-47.991-51.64-27.161-68.318-76.889-90.54-68.371-65.238-87.971-92.37-81.545-76.4147.5127.512
Operating Income Ratio -2.27-3.913-5.605-6.479-1.331-1.241-0.483-5.095-5.703-10.741-4.264-3.388-12.005-7.762-8.233-4.1450.0680.068
Total Other Income Expenses Net 45.235-4.0193.059-18.022.7594.6194.0010.439-0.5144.8297.3345.1893.8824.8055.6215.1676.8686.868
Income Before Tax 24.879-52.673-56.822-71.638-42.089-47.021-23.16-67.879-77.403-85.711-60.974-60.001-84.042-87.196-76.801-72.07514.3814.38
Income Before Tax Ratio 2.775-4.236-5.318-5.953-1.168-1.13-0.412-5.063-5.741-10.169-3.803-3.116-11.469-7.327-7.754-3.910.1310.131
Income Tax Expense 02.064-9.51517.098-3.037-4.546-0.017-0.4390.017-4.781-3.6480.0480.0470.36923.647-0.82800
Net Income 24.879-52.673-56.822-71.638-42.089-42.475-23.143-67.44-77.42-80.93-60.974-60.001-84.042-87.196-76.801-72.07514.3814.38
Net Income Ratio 2.775-4.236-5.318-5.953-1.168-1.021-0.412-5.03-5.742-9.601-3.803-3.116-11.469-7.327-7.754-3.910.1310.131
EPS 0.48-1.01-1.11-1.4-0.83-0.98-0.6-1.75-2.02-3.03-2.59-2.58-3.61-3.74-3.3-3.10.6170.617
EPS Diluted 0.45-1.01-1.11-1.4-0.83-0.98-0.6-1.75-2.02-3.03-2.55-2.58-3.61-3.74-3.3-3.10.6170.617
EBITDA -18.68-46.547-56.851-33.758-45.647-49.312-24.785-65.891-73.505-86.962-68.421-60.475-83.405-87.956-55.456-74.73210.77810.778
EBITDA Ratio -2.083-3.743-5.321-2.805-1.266-1.185-0.441-4.914-5.452-10.317-4.268-3.14-11.382-7.391-5.599-4.0540.0980.098